CELL REP 润色咨询

Cell Reports

出版年份:暂无数据 年文章数:10575 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:molecular biology<br>经验分享:难度不低,影响因子不高,不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊,SA,NC之类的冲上不去,工作量挺大的,发了cell rep。感觉略亏了,但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿,今年1月接收,历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向:肠道微生物与宿主互作<br>经验分享:12月16号投的,23号under review,今天2月14号了,快2个月了,还没有消息,各位一般一审多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向:肿瘤<br>经验分享:文章质量很好,不明白为什么一直上不去10呢?难道是不怎么发综述吗?很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问各位前辈,under review代表送审了吗?为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问under review是送审了吗?为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢,编辑态度很好,review意见专业,根据我的经验这个期刊算不上水刊,而且在国外认可度还不错,毕竟不靠发review拉分,唯一的就是版面费不便宜,cell press旗下,看好未来!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=)]
    2024-02-07 黑鬼儿 来自河北省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:molecular biology
    经验分享:难度不低,影响因子不高,不划算

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:molecular biology<br>经验分享:难度不低,影响因子不高,不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊,SA,NC之类的冲上不去,工作量挺大的,发了cell rep。感觉略亏了,但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿,今年1月接收,历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向:肠道微生物与宿主互作<br>经验分享:12月16号投的,23号under review,今天2月14号了,快2个月了,还没有消息,各位一般一审多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向:肿瘤<br>经验分享:文章质量很好,不明白为什么一直上不去10呢?难道是不怎么发综述吗?很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问各位前辈,under review代表送审了吗?为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问under review是送审了吗?为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢,编辑态度很好,review意见专业,根据我的经验这个期刊算不上水刊,而且在国外认可度还不错,毕竟不靠发review拉分,唯一的就是版面费不便宜,cell press旗下,看好未来!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=)]
    2022-06-02 cindichaw

    年初接收了一篇。因为顶刊大子刊,SA,NC之类的冲上不去,工作量挺大的,发了cell rep。感觉略亏了,但杂志声望和评审细致都还可以。

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:molecular biology<br>经验分享:难度不低,影响因子不高,不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊,SA,NC之类的冲上不去,工作量挺大的,发了cell rep。感觉略亏了,但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿,今年1月接收,历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向:肠道微生物与宿主互作<br>经验分享:12月16号投的,23号under review,今天2月14号了,快2个月了,还没有消息,各位一般一审多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向:肿瘤<br>经验分享:文章质量很好,不明白为什么一直上不去10呢?难道是不怎么发综述吗?很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问各位前辈,under review代表送审了吗?为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问under review是送审了吗?为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢,编辑态度很好,review意见专业,根据我的经验这个期刊算不上水刊,而且在国外认可度还不错,毕竟不靠发review拉分,唯一的就是版面费不便宜,cell press旗下,看好未来!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=)]
    2024-01-22 ms2000001775137343 来自安徽省

    6月投稿,今年1月接收,历时7个月

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:molecular biology<br>经验分享:难度不低,影响因子不高,不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊,SA,NC之类的冲上不去,工作量挺大的,发了cell rep。感觉略亏了,但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿,今年1月接收,历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向:肠道微生物与宿主互作<br>经验分享:12月16号投的,23号under review,今天2月14号了,快2个月了,还没有消息,各位一般一审多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向:肿瘤<br>经验分享:文章质量很好,不明白为什么一直上不去10呢?难道是不怎么发综述吗?很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问各位前辈,under review代表送审了吗?为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问under review是送审了吗?为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢,编辑态度很好,review意见专业,根据我的经验这个期刊算不上水刊,而且在国外认可度还不错,毕竟不靠发review拉分,唯一的就是版面费不便宜,cell press旗下,看好未来!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=)]
    2024-01-17 ms9000001460504456 来自广东省

    请问今年影响因子能涨吗?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:molecular biology<br>经验分享:难度不低,影响因子不高,不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊,SA,NC之类的冲上不去,工作量挺大的,发了cell rep。感觉略亏了,但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿,今年1月接收,历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向:肠道微生物与宿主互作<br>经验分享:12月16号投的,23号under review,今天2月14号了,快2个月了,还没有消息,各位一般一审多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向:肿瘤<br>经验分享:文章质量很好,不明白为什么一直上不去10呢?难道是不怎么发综述吗?很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问各位前辈,under review代表送审了吗?为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问under review是送审了吗?为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢,编辑态度很好,review意见专业,根据我的经验这个期刊算不上水刊,而且在国外认可度还不错,毕竟不靠发review拉分,唯一的就是版面费不便宜,cell press旗下,看好未来!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=)]
    2023-02-14 朋友一场 来自北京

    偏重的研究方向:肠道微生物与宿主互作
    经验分享:12月16号投的,23号under review,今天2月14号了,快2个月了,还没有消息,各位一般一审多久呀?

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:molecular biology<br>经验分享:难度不低,影响因子不高,不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊,SA,NC之类的冲上不去,工作量挺大的,发了cell rep。感觉略亏了,但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿,今年1月接收,历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向:肠道微生物与宿主互作<br>经验分享:12月16号投的,23号under review,今天2月14号了,快2个月了,还没有消息,各位一般一审多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向:肿瘤<br>经验分享:文章质量很好,不明白为什么一直上不去10呢?难道是不怎么发综述吗?很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问各位前辈,under review代表送审了吗?为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问under review是送审了吗?为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢,编辑态度很好,review意见专业,根据我的经验这个期刊算不上水刊,而且在国外认可度还不错,毕竟不靠发review拉分,唯一的就是版面费不便宜,cell press旗下,看好未来!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=)]
    2022-03-09 hppv587

    二审一个月了还没消息

    15

    展开15条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:molecular biology<br>经验分享:难度不低,影响因子不高,不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊,SA,NC之类的冲上不去,工作量挺大的,发了cell rep。感觉略亏了,但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿,今年1月接收,历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向:肠道微生物与宿主互作<br>经验分享:12月16号投的,23号under review,今天2月14号了,快2个月了,还没有消息,各位一般一审多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向:肿瘤<br>经验分享:文章质量很好,不明白为什么一直上不去10呢?难道是不怎么发综述吗?很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问各位前辈,under review代表送审了吗?为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问under review是送审了吗?为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢,编辑态度很好,review意见专业,根据我的经验这个期刊算不上水刊,而且在国外认可度还不错,毕竟不靠发review拉分,唯一的就是版面费不便宜,cell press旗下,看好未来!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=)]
    2023-07-13 poiju 来自上海

    偏重的研究方向:肿瘤
    经验分享:文章质量很好,不明白为什么一直上不去10呢?难道是不怎么发综述吗?很多文章明显比有的10+期刊还好😅

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:molecular biology<br>经验分享:难度不低,影响因子不高,不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊,SA,NC之类的冲上不去,工作量挺大的,发了cell rep。感觉略亏了,但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿,今年1月接收,历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向:肠道微生物与宿主互作<br>经验分享:12月16号投的,23号under review,今天2月14号了,快2个月了,还没有消息,各位一般一审多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向:肿瘤<br>经验分享:文章质量很好,不明白为什么一直上不去10呢?难道是不怎么发综述吗?很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问各位前辈,under review代表送审了吗?为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问under review是送审了吗?为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢,编辑态度很好,review意见专业,根据我的经验这个期刊算不上水刊,而且在国外认可度还不错,毕竟不靠发review拉分,唯一的就是版面费不便宜,cell press旗下,看好未来!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=)]
    2023-06-14 ms7000001335611101 来自天津

    偏重的研究方向:医学;肿瘤
    经验分享:请问各位前辈,under review代表送审了吗?为什么没有收到邮件呢

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:molecular biology<br>经验分享:难度不低,影响因子不高,不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊,SA,NC之类的冲上不去,工作量挺大的,发了cell rep。感觉略亏了,但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿,今年1月接收,历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向:肠道微生物与宿主互作<br>经验分享:12月16号投的,23号under review,今天2月14号了,快2个月了,还没有消息,各位一般一审多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向:肿瘤<br>经验分享:文章质量很好,不明白为什么一直上不去10呢?难道是不怎么发综述吗?很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问各位前辈,under review代表送审了吗?为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问under review是送审了吗?为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢,编辑态度很好,review意见专业,根据我的经验这个期刊算不上水刊,而且在国外认可度还不错,毕竟不靠发review拉分,唯一的就是版面费不便宜,cell press旗下,看好未来!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=)]
    2023-06-14 ms7000001335611101 来自天津

    偏重的研究方向:医学;肿瘤
    经验分享:请问under review是送审了吗?为什么没收到邮件呢

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2186331, encodeId=cf2e2186331f6, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:molecular biology<br>经验分享:难度不低,影响因子不高,不划算, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a552358842, createdName=黑鬼儿, createdTime=Wed Feb 07 11:51:41 CST 2024, time=2024-02-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊,SA,NC之类的冲上不去,工作量挺大的,发了cell rep。感觉略亏了,但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183140, encodeId=e78f218314022, content=6月投稿,今年1月接收,历时7个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22458475435, createdName=ms2000001775137343, createdTime=Mon Jan 22 10:54:10 CST 2024, time=2024-01-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2182232, encodeId=9a4a21822324e, content=请问今年影响因子能涨吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c715296884, createdName=ms9000001460504456, createdTime=Wed Jan 17 17:00:10 CST 2024, time=2024-01-17, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2114571, encodeId=6f6921145e1ca, content=偏重的研究方向:肠道微生物与宿主互作<br>经验分享:12月16号投的,23号under review,今天2月14号了,快2个月了,还没有消息,各位一般一审多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcea1641911, createdName=朋友一场, createdTime=Tue Feb 14 14:00:57 CST 2023, time=2023-02-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1201019, encodeId=cca212010196f, content=二审一个月了还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae622062117, createdName=hppv587, createdTime=Wed Mar 09 20:09:57 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147882, encodeId=da44214e88293, content=偏重的研究方向:肿瘤<br>经验分享:文章质量很好,不明白为什么一直上不去10呢?难道是不怎么发综述吗?很多文章明显比有的10+期刊还好😅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=poiju, createdTime=Thu Jul 13 18:40:43 CST 2023, time=2023-07-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问各位前辈,under review代表送审了吗?为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向:医学;肿瘤<br>经验分享:请问under review是送审了吗?为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2097970, encodeId=0397209e97070, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:20220428 submitted<br>20220506 under review<br>20220622 all reviews complete<br>20220623 major revision<br>20220822 revised<br>20221018 pre-accept<br>20221101 accept<br>整个投稿过程不快不慢,编辑态度很好,review意见专业,根据我的经验这个期刊算不上水刊,而且在国外认可度还不错,毕竟不靠发review拉分,唯一的就是版面费不便宜,cell press旗下,看好未来!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epp0ckGW2QpfZ3gTrwEibm4B4iaZcibTfdAGuibaGibrWRxUSyIpnHiao7Q61bLCqE7RMvTUbVntiaZCIO2g/132, createdBy=d7a42465704, createdName=苦逼科研仔, createdTime=Tue Nov 01 23:47:24 CST 2022, time=2022-11-01, status=1, ipAttribution=)]
    2022-11-01 苦逼科研仔

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:20220428 submitted
    20220506 under review
    20220622 all reviews complete
    20220623 major revision
    20220822 revised
    20221018 pre-accept
    20221101 accept
    整个投稿过程不快不慢,编辑态度很好,review意见专业,根据我的经验这个期刊算不上水刊,而且在国外认可度还不错,毕竟不靠发review拉分,唯一的就是版面费不便宜,cell press旗下,看好未来!

    1

    展开1条回复
共354条页码: 1/36页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分